Affinity Chromatography of Kinases and Dehydrogenases on Sephadex® and Sepharose® Dye Derivatives

  • Richard L. Easterday
  • Inger M. Easterday
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 42)


Biospecific affinity chromatography has been shown to be a powerful method for the isolation of biological compounds1,2. While high specificity of the immobilized ligand for the compound of interest generally results in high purification factors and simple isolation protocols, it usually necessitates the often laborious synthesis of a special affinity adsorbent. Affinity gels with group rather than compound specificity therefore have the potential advantage of being useful for the isolation of many compounds belonging to a particular group. The resolving po!’.er of these gels need not be less than the more compound specific gels, since highly selective compound elution is still possible with substrates, cofactors, or inhibitors.


Creatine Kinase Pyruvate Kinase Blue Dextran Cibacron Blue Cibacron Blue F3GA 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    P. Cuatrecasas and C.B. Anfinsen, Methods in Enzymology, 22, 345 (1971).CrossRefGoogle Scholar
  2. 2.
    J. Porath and T. Kiristiansen, The Proteins, Vol. I, 3rd Ed. (1973).Google Scholar
  3. 3.
    G. Kopperschläger, R. Freyer, W. Diezel, and E. Hofmann, FEBS Letters, 1, 137 (1968).CrossRefGoogle Scholar
  4. 4.
    G. Kopperschläger, W. Diezel, R. Freyer, S. Liebe, E. Hofmann, Eur. J. Biochem., 22, 40 (1971).CrossRefGoogle Scholar
  5. 5.
    H. Haeckel, B. Hess, W. Lauterborn, and K.H. Wíister, HoppeSeyler’s Z. Physiol. Chem., 349, 699 (1968).CrossRefGoogle Scholar
  6. 6.
    K.G. Blume, R.W. Hoffbauer, D. Busch, H. Arnold, G.W. Löhr, Biochim. Biophys. Acta, 227, 364 (1971).Google Scholar
  7. 7.
    G. E. Staal, J.F. Koster, H. Kamp, L. Van-Milligen-Boersma, C. Veeger, Biochim. Biophys. Acta, 227, 86 (1971).Google Scholar
  8. 8.
    G.E. Staal, J. Visser, C. Veeger, Biochim. Biophys. Acta, 185, 39 (1969).Google Scholar
  9. 9.
    H.D. White and W.P. Jencks, Amer. Chem. Soc. Meeting Abstracts, Abstr. No. 43, (1970).Google Scholar
  10. 10.
    A.C.W. Swart and H.C. Hemker, Biochim, Biophys. Acta, 222, 692 (1970).CrossRefGoogle Scholar
  11. 11.
    J.J. Marshall, J. Chromatogr., 53, 379 (1970).CrossRefGoogle Scholar
  12. 12.
    H.J. Böhme, G. Kopperschläger, J. Schulz, and E. Hofmann, J. Chromatogr., 69, 209 (1972).CrossRefGoogle Scholar
  13. 13.
    J. Porath, J.C. Janson, and T. Lus, J. Chromatogr., 60, 167 (1971).CrossRefGoogle Scholar
  14. 14.
    J. Travis and R. Pannell, Clinica Chimica Acta (to be published)Google Scholar

Copyright information

© Plenum Press, New York 1974

Authors and Affiliations

  • Richard L. Easterday
    • 1
  • Inger M. Easterday
    • 1
  1. 1.Pharmacia Fine Chemicals Inc.PiscatawayUSA

Personalised recommendations